Abbott launches MRD test with improved cancer detection tech

Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top